Does Rallies show Form 4 insider transactions for SHC?

Yes. Rallies tracks SHC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is SHC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SHC. It does not provide personalized investment advice.

SHC (Sotera Health Company Common Stock) Stock Analysis - Insider Trades

Sotera Health Company Common Stock (SHC) is a publicly traded Healthcare sector company. As of May 20, 2026, SHC trades at $15.54 with a market cap of $4.38B and a P/E ratio of 37.65. SHC moved +2.04% today. Year to date, SHC is -15.03%; over the trailing twelve months it is +21.29%. Its 52-week range spans $9.53 to $19.85. Analyst consensus is strong buy with an average price target of $22.17. Rallies surfaces SHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading SHC stock inside the company?

Recent SHC insider activity includes WARBURG PINCUS & CO. sold 19.10M, WARBURG PINCUS & CO. sold 19.10M, GTCR INVESTMENT XI LLC sold 12.74M, WARBURG PINCUS & CO. sold 15.00M, and WARBURG PINCUS & CO. sold 15.00M. Rallies tracks insider transaction dates, shares, prices, and estimated values.

SHC Key Metrics

Key financial metrics for SHC
Metric	Value
Price	$15.54
Market Cap	$4.38B
P/E Ratio	37.65
EPS	$0.41
Dividend Yield	0.00%
52-Week High	$19.85
52-Week Low	$9.53
Volume	2.12M
Avg Volume	0
Revenue (TTM)	$1.19B
Net Income	$117.80M
Gross Margin	55.26%

Recent SHC Insider Trades

WARBURG PINCUS & CO. sold 19.10M (~$289.75M) on May 13, 2026.
WARBURG PINCUS & CO. sold 19.10M (~$289.75M) on May 13, 2026.
GTCR INVESTMENT XI LLC sold 12.74M (~$193.17M) on May 13, 2026.
WARBURG PINCUS & CO. sold 15.00M (~$229.05M) on Mar 6, 2026.
WARBURG PINCUS & CO. sold 15.00M (~$229.05M) on Mar 6, 2026.

Latest SHC News

Sotera Health Affiliates Offer 31.8 Million Shares, Company Receives No Proceeds — May 11, 2026
Sotera Health Sees 10% Q1 Revenue Growth, Names Alton Shader CEO — May 5, 2026
Sotera Health Q1 Revenue Forecast at $270M, EPS Seen $0.09 — May 4, 2026
Sotera Health Affiliates to Sell 25 Million Shares in Secondary Offering — Mar 4, 2026
Sotera Health Q4 Revenue Rises 4.6% to $303.4M, EPS Tops Forecast — Feb 24, 2026

SHC Analyst Consensus

6 analysts cover SHC: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.17.

Common questions about SHC

Who is trading SHC stock inside the company?: Recent SHC insider activity includes WARBURG PINCUS & CO. sold 19.10M, WARBURG PINCUS & CO. sold 19.10M, GTCR INVESTMENT XI LLC sold 12.74M, WARBURG PINCUS & CO. sold 15.00M, and WARBURG PINCUS & CO. sold 15.00M. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for SHC?: Yes. Rallies tracks SHC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SHC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SHC. It does not provide personalized investment advice.